Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens.
about
The pharmacology of lysergic acid diethylamide: a review.Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens.The behavioral pharmacology of hallucinogensTrace amine-associated receptor 1-Family archetype or iconoclast?Epigenetic mechanisms in schizophreniaComparative potencies of 3,4-methylenedioxymethamphetamine (MDMA) analogues as inhibitors of [3H]noradrenaline and [3H]5-HT transport in mammalian cell linesFunctional characterization of agonists at recombinant human 5-HT2A, 5-HT2B and 5-HT2C receptors in CHO-K1 cellsMechanism of the 5-hydroxytryptamine 2A receptor-mediated facilitation of synaptic activity in prefrontal cortexRecent advances in the neuropsychopharmacology of serotonergic hallucinogensCellular and subcellular distribution of the serotonin 5-HT2A receptor in the central nervous system of adult ratPsychosis in Parkinson's Disease: Epidemiology, Pathophysiology, and Management.Looking for the Self: Phenomenology, Neurophysiology and Philosophical Significance of Drug-induced Ego Dissolution.Neuropharmacology of the naturally occurring kappa-opioid hallucinogen salvinorin A5-HT(2A) and 5-HT(2C) receptors exert opposing effects on locomotor activity in miceLSD but not lisuride disrupts prepulse inhibition in rats by activating the 5-HT(2A) receptor.Behavioural evidence for functional interactions between 5-HT-receptor subtypes in rats and mice.Modification of the effects of 5-methoxy-N,N-dimethyltryptamine on exploratory behavior in rats by monoamine oxidase inhibitors.Serotonin 5HT2 receptor imaging in the human brain using positron emission tomography and a new radioligand, [18F]altanserin: results in young normal controls.Effects of clozapine and 2,5-dimethoxy-4-methylamphetamine [DOM] on 5-HT2A receptor expression in discrete brain areas.The hallucinogenic world of tryptamines: an updated review.Pharmacokinetics and Concentration-Effect Relationship of Oral LSD in Humans.Clinical applications of hallucinogens: A review.A new approach for studying GPCR dimers: drug-induced inactivation and reactivation to reveal GPCR dimer function in vitro, in primary culture, and in vivoRegulation of 5-HT2A/C receptors and DOI-induced behaviors by protein kinase Cgamma.New trends in the cyber and street market of recreational drugs? The case of 2C-T-7 ('Blue Mystic').Discriminative stimulus effects of N,N-diisopropyltryptamineSalvinicins A and B, new neoclerodane diterpenes from Salvia divinorum.Behavioral effects of α,α,β,β-tetradeutero-5-MeO-DMT in rats: comparison with 5-MeO-DMT administered in combination with a monoamine oxidase inhibitorNeurotoxic Effects of 5-MeO-DIPT: A Psychoactive Tryptamine Derivative in Rats.Role of the 5-HT₂A receptor in the locomotor hyperactivity produced by phenylalkylamine hallucinogens in mice.Behavioral and neurochemical pharmacology of six psychoactive substituted phenethylamines: mouse locomotion, rat drug discrimination and in vitro receptor and transporter binding and function.Irving Page Lecture: 5-HT(2A) serotonin receptor biology: interacting proteins, kinases and paradoxical regulation.5-Hydroxytryptamine 2A receptor antagonists as potential treatment for psychiatric disorders.Diversity and Bias through Receptor-Receptor Interactions in GPCR Heteroreceptor Complexes. Focus on Examples from Dopamine D2 Receptor Heteromerization.Topiramate-induced Dissociative Disorder.Optimising PET approaches to measuring 5-HT release in human brain.Pharmacology and Toxicology of N-Benzylphenethylamine ("NBOMe") Hallucinogens.Discovery and development of 5-HT(₂C) receptor agonists for obesity: is there light at the end of the tunnel?The role of 5-hydroxytryptamine (5-HT) receptor subtypes and plasticity in the 5-HT systems in the regulation of nociceptive sensitivity.3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy"): pharmacology and toxicology in animals and humans.
P2860
Q22242295-3C5F64F3-4E60-4B49-A975-EBC9A4F12298Q24620764-4D26C443-75E4-4BCD-8FCA-0288C149D0E9Q24645656-6074DC57-18A4-4C9B-B193-EE265848C121Q24648659-EEC07DBD-C77C-4C52-AC87-312E5403872BQ24654169-D7F83BE0-D226-4AA1-9201-D683D42D5E94Q24670108-F5FB9361-2F6D-41D2-9953-D06F299324DAQ24675490-1F264E9B-93D4-4244-95C7-3D054F992B3CQ24676304-055DF213-E322-440E-AEFB-8F1F97E53250Q27027381-E34B2673-3831-46C4-8326-F2BAC14C7969Q28565096-99A85863-D413-4B4E-B790-7996BA32C8C9Q30249553-DEEACBD4-0218-4FF8-9034-D0C1272CFEDCQ30402789-A29CF32E-99F1-42FB-844A-62EE35F51B8CQ30467220-186BA7A8-F5F7-42AF-B6C7-67FCB5F7307DQ30484420-6AEAE4B1-0AC5-4BD5-B4C7-5090D55B227FQ30484494-1BC0277B-1ED3-4AD1-BE02-723F0C5F4BF8Q30498829-18255E59-BCF3-418B-94E9-43DCC289F8BAQ34087847-ABCB6621-D977-47F3-93CF-291FD789A94BQ34305236-85CE024A-CF5A-4990-A16E-111CC3315A86Q34313092-C8AB6728-5673-4D97-8D0A-18CCE5464C38Q34471834-1FE52F38-A11B-4B7D-B2AE-54694C92D1D7Q34482174-7EF66047-8B9F-495A-B2A4-344D989233EBQ34535259-9A971CA0-07C0-4DA5-B9D9-6ECF55FEEBA3Q35713438-2C674B50-8E5C-4A36-A738-8ADB19D8C224Q35792549-05314D14-770C-4EE2-B867-9889902E2961Q36307104-83F8E3E7-44AA-4D92-98DB-6B56A17C6F68Q36625158-80F1C27E-86D7-47F1-BD2B-DB706CFAD98CQ36873376-ACB501CB-FC1C-4FEB-9EC4-3DB9788D3EABQ37230473-0C6563E0-6AA5-4CDC-8436-6CB2594F0ACAQ37306537-2CA53F51-4476-4D42-B828-FF121EBBDF47Q37602790-165F2109-1CC6-41D6-86CC-8F855D02EA21Q37622283-CE6F4CCF-03B3-47BC-96A7-7603385E6782Q37834732-5F31DD68-D919-4D67-9C96-598DD21B86FCQ38081485-41E8FE72-B588-427D-A439-F9D73AD4A7B1Q38214620-EB232B79-6FC8-454D-B618-DE136F5B8A2AQ38440764-239E2082-C0BF-493B-8E30-E2617AD6C785Q38531787-E4F14F0B-8A6A-4797-AAB3-D0CBB1D26C8FQ39093171-BA4B5DD2-91F4-4CE1-9721-5B8A23C63F48Q39768889-BC63B05D-067C-461A-A898-54A4DA1FC1E2Q40486987-1ACA0B58-4E8C-436B-A753-27069CEE85A3Q40624643-D08E636F-4652-4D04-B530-2803E44CCC7C
P2860
Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens.
description
1988 nî lūn-bûn
@nan
1988 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
name
Radioligand binding evidence i ...... lisopropylamine hallucinogens.
@ast
Radioligand binding evidence i ...... lisopropylamine hallucinogens.
@en
Radioligand binding evidence i ...... lisopropylamine hallucinogens.
@nl
type
label
Radioligand binding evidence i ...... lisopropylamine hallucinogens.
@ast
Radioligand binding evidence i ...... lisopropylamine hallucinogens.
@en
Radioligand binding evidence i ...... lisopropylamine hallucinogens.
@nl
prefLabel
Radioligand binding evidence i ...... lisopropylamine hallucinogens.
@ast
Radioligand binding evidence i ...... lisopropylamine hallucinogens.
@en
Radioligand binding evidence i ...... lisopropylamine hallucinogens.
@nl
P2093
P356
P1433
P1476
Radioligand binding evidence i ...... lisopropylamine hallucinogens.
@en
P2093
P2888
P304
P356
10.1007/BF00176847
P577
1988-01-01T00:00:00Z
P6179
1028252266